Cargando…
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymes
Metastatic prostate cancer remains uncurable. In this issue of Cell Reports Medicine, Rice et al. present an assessment of a compound (SU086) demonstrating activity in prostate cancer models through heat shock protein 90 inhibition and cell metabolism changes.
Autores principales: | Plymate, Stephen R., Sprenger, Cynthia, Haffner, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861633/ https://www.ncbi.nlm.nih.gov/pubmed/35243412 http://dx.doi.org/10.1016/j.xcrm.2021.100493 |
Ejemplares similares
-
Enzyme-based assay for quantification of UDP-GlcNAc in cells and tissues
por: Chatham, John C., et al.
Publicado: (2023) -
Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022) -
Identifying inflammatory phenotypes to target mechanism-specific treatments in sepsis
por: Gómez, Hernando, et al.
Publicado: (2022) -
Tipping the GVH/GVL balance by targeting HIF1α
por: Wu, Yongxia, et al.
Publicado: (2023) -
Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?
por: Prinzing, Brooke, et al.
Publicado: (2021)